Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases

Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases

This study aimed to investigate the use of Plasma Rich in Growth Factors (PRGF) associated with tissue ReGeneraTing Agent (RGTA) drops for the treatment of noninfectious corneal ulcers. RGTA treatment was applied (one drop every two days); however, if ulcer closure was not achieved, PRGF eye drops t...

Full description

Bibliographic Details
Main Authors: Ronald M. Sánchez-Ávila, Edmar Uribe-Badillo, Carlos Fernández-Vega González, Francisco Muruzabal, Borja de la Sen-Corcuera, Begoña Baamonde, Luis M. Quirós, Eduardo Anitua, Jesús Merayo-Lloves
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Vision
Subjects:
PRGF
RGTA matrix
ocular surface diseases
PRP
corneal ulcers
Online Access:https://www.mdpi.com/2411-5150/5/3/34

Internet

https://www.mdpi.com/2411-5150/5/3/34

Similar Items